Experience and Outcomes of Utilizing a High Risk Identification Program with Liese Vito, MD

• This webinar is designed to discuss the pressures of evaluating patients for hereditary cancer risks and new technologies that simplify and improve the ability to do so as well as provide much improved compliance with testing when appropriate. The Lake Health System (a community-based system) has been performing routine risk assessments for over 2 years now and it serves as a robust example of how the testing can be performed in the course of routine office visits. Data of the outcomes will be reviewed and hopefully serve as an impetus for others to consider similar models.

  Level of Instruction: Basic

  

  Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

  

  Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Liese Vito, MD | Presenter

Obstetrician-Gynecologist, Lake Health Physician Group Women’s Health Specialists

Dr. Liese Vito has a BA in biology from Washington & Jefferson College and received her MD at The University of Pennsylvania School of Medicine (now known as the Perelman School of Medicine). Dr. Vito completed a residency in OB/GYN at MetroHealth Medical Center in Cleveland, Ohio. She is a fellow of the American Congress of OB/GYN. Dr. Vito has practiced for over 26 years in the Lake Health System in Lake County, Ohio. In addition, she now serves as the medical director of the Cancer Prevention Program at her institution. 

Dr. Vito enjoys being a member of the local community and has served in a number of volunteer opportunities including a medical mission trip to Ganta Mission in Liberia in 2017. 

Her husband practices ENT and they have two adult children, Alexandra and Matthew—both engineers.

Sarah Campian, MS, CGC | Moderator

Genomic Science Liaison, Ambry Genetics

Sarah Campian joined Ambry Genetics in 2018 as the Oncology Genetic Specialist for the Great Lakes territory. She previously worked as a clinical genetic counselor at the Grosfeld Cancer Genetics Center at Beaumont Health. Her research interests include Lynch syndrome and identification of gene mutation carriers in minority populations. Sarah received her Bachelors of Science degree in Biology from Saginaw Valley State University. She earned her Masters of Science degree in Genetic Counseling from Wayne State University and is certified by the American Board of Genetic Counseling.